PRESS RELEASE published on 05/29/2024 at 18:30, 1 year 9 months ago PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD PREDILIFE obtains European patent for its AI breast cancer risk prediction method, reinforcing its assets. The method's strong performance and diverse applications position it as a valuable asset in the field of predictive medicine PREDILIFE Breast Cancer Predictive Medicine European Patent AI Method
PRESS RELEASE published on 05/29/2024 at 18:30, 1 year 9 months ago PREDILIFE RENFORCE SES ACTIFS GRACE A LA DELIVRANCE DU BREVET SUR SA METHODE D'INTELLIGENCE ARTIFICIELLE Predilife renforce ses actifs avec la délivrance du brevet sur sa méthode d'intelligence artificielle pour prédire les risques de pathologies. Le brevet renforce la protection du logiciel MammoRisk® et a été valorisé à 207 M€ Intelligence Artificielle IA Brevet PREDILIFE Prédiction
BRIEF published on 05/01/2024 at 08:05, 1 year 10 months ago PREDILIFE reçoit une analyse boursière mise à jour d'In Extenso Finance In Extenso Finance Analyse Des Stocks PRÉDIVIE Santé IA MammoRisque
BRIEF published on 05/01/2024 at 08:05, 1 year 10 months ago PREDILIFE Receives Updated Stock Analysis from In Extenso Finance AI Healthcare In Extenso Finance Stock Analysis PREDILIFE MammoRisk
PRESS RELEASE published on 05/01/2024 at 08:00, 1 year 10 months ago IN EXTENSO FINANCE UPDATES COVERAGE ON PREDILIFE STOCK; TARGET PRICE OF EUR 25.07 REPRESENTS +391% POTENTIAL UPSIDE In Extenso Finance updates coverage on Predilife stock, raising target price to €25.07 (+391% potential upside). Predilife pioneers in AI for personalized medicine Target Price In Extenso Finance Personalized Medicine Predilife Stock AI Methods
PRESS RELEASE published on 05/01/2024 at 08:00, 1 year 10 months ago ACTUALISATION DE LA COUVERTURE DU TITRE PREDILIFE PAR IN EXTENSO FINANCE ; OBJECTIF DE COURS DE 25,07 EUR SOIT +391% Predilife actualise son objectif de cours avec In Extenso Finance, visant 25,07€ (+391%). Renforcement de sa propriété intellectuelle et contrat de recherche avec In Extenso Financement & Marché Intelligence Artificielle Objectif De Cours Propriété Intellectuelle In Extenso Finance PREDILIFE
BRIEF published on 04/30/2024 at 18:05, 1 year 10 months ago Results of the Ordinary and Extraordinary General Meeting of Predilife Annual Accounts General Assembly Company Shares PREDILIFE Company Administration
BRIEF published on 04/30/2024 at 18:05, 1 year 10 months ago Résultats de l'Assemblée Générale Ordinaire et Extraordinaire de Predilife Assemblée Générale Comptes Annuels Actions De La Société PREDILIFE Administration De L'entreprise
PRESS RELEASE published on 04/30/2024 at 18:00, 1 year 10 months ago RÉSULTATS DE L'ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DE PREDILIFE Communiqué de presse annonçant les résultats de l'assemblée générale ordinaire et extraordinaire de Predilife, société spécialisée en IA pour prédire les risques de pathologies Résultats Financiers Assemblée Générale Intelligence Artificielle PREDILIFE Prédiction Maladies
BRIEF published on 04/25/2024 at 18:10, 1 year 10 months ago Valorization of the MammoRisk® software by PREDILIFE Artificial Intelligence PREDILIFE MammoRisk Software Evaluation Breast Cancer
Published on 03/23/2026 at 02:00, 4 hours 43 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 17 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 3 hours 8 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 18 hours 20 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 7 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 9 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 11 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 11 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA